Trials / Unknown
UnknownNCT02528422
The Effect of Acyl-Ghrelin on Kidney Function and Blood Pressure in Healthy Volunteers
The Effect of Acyl-Ghrelin on Kidney Function and Blood Pressure in Healthy Volunteers - A Randomized, Cross-over, Single-blind, Placebo-controlled Dose-response Study of the Acyl-ghrelin Induced Effects on GFR, Tubular Transport of Sodium and Water in Different Nephron Segments and Central and Peripheral Blood Pressure
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- Erling Bjerregaard Pedersen · Academic / Other
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Ghrelin (growth hormone release inducer) is produced in the stomach. The active form of Ghrelin is Acyl-Ghrelin. Acyl-Ghrelin stimulates the Ghrelin receptors. Ghrelin receptors are detected in the distal tubules in mice and animal studies have shown that Ghrelin increases the absorption of sodium in the renal tubules. Ghrelin infusion directly into the renal artery of rats increased sodium reabsorption in the distal nephron, presumably via the epithelial sodium channels (ENaC). The purpose of the study is to measure the acyl-ghrelin induced effects on GFR, tubular transport of sodium and water in different nephron segments and central and peripheral blood pressure in a randomized, cross-over, single-blind, placebo-controlled dose-response study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Acyl-Ghrelin |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2018-01-01
- Completion
- 2018-01-01
- First posted
- 2015-08-19
- Last updated
- 2015-08-19
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02528422. Inclusion in this directory is not an endorsement.